Metastatic melanoma of the heart: Retrospective cohort study and systematic review of prevalence, clinical characteristics, and outcomes
Alexander M. Balinski(Oakland University), Salim S. Hayek(Rush University Medical Center), Leslie A. Fecher(University of Pennsylvania), Raymond Y. Yeow(University of Michigan), Pennelope Blakely(University of Michigan), Connor C. Kerndt(Spectrum Health), Tonimarie Catalan(University of Michigan), Nathan Parry(Oakland University), Alexi Vasbinder(University of Washington), Monika Leja(University of Michigan), Christopher D. Lao(University of Michigan), Rafey Rehman(Wayne State University)
Cited by 28
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k
Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
|Science Translational Medicine|2011|637
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
|JAMA Internal Medicine|2020|555
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
|The Lancet Oncology|2012|541